$ZNTL Income Statement | Understand Stock

$ZNTL

$2.07 -$0.14 (6.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues from Licensing and Sales of Intellectual Property
Operating Expenses
Research and development
Zentera in-process research and development
General and administrative
Restructuring
Goodwill impairment
Total operating expenses
Loss from operations
Other Income (Expense)
Investment and other income, net
Gain on deconsolidation of Zentera
Net loss before income taxes
Income tax expense (benefit)
Loss on equity method investment
Net loss
Net loss attributable to noncontrolling interests
Net loss attributable to Zentalis
Net loss per common share outstanding, basic (in dollars per share)
Class A Common Units
Common Stock
Total net loss per common share outstanding, basic (in dollars per share)

Net loss per common share outstanding, diluted (in dollars per share)
Common Stock
Total net loss per common share outstanding, diluted (in dollars per share)

Common shares used in computing net loss per share, basic (in shares)
Common shares used in computing net loss per share, diluted (in shares)

Comments